Rakesh Jain, MD, MPH clarifies the diagnostic overlap and treatment approaches.
Supported by an independent educational grant from Intra-Cellular Therapies, Inc.
Rakesh Jain, MD, MPH clarifies the diagnostic overlap and treatment approaches.
Michael Asbach, DMSc, PA-C discusses cardiometabolic risks and tolerability trade-offs in BD meds.